HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sun, J. Articles by Pearce, E. J. Search for Related Content PubMed PubMed Citation Articles by Sun, J. Articles by Pearce, E. J.

Suppression of Early IL-4 Production Underlies the Failure of CD4 T Cells Activated by TLR-Stimulated Dendritic Cells to Differentiate into Th2 Cells¹

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104

Dendritic cells (DCs) activated through TLRs provide a potent negative signal for Th2 cell development that is independent of positive signals for Th1 cell development such as IL-12 and IFN-. In this study we demonstrate that the ability of TLR-activated DCs to suppress Th2 cell development is Ag dose-independent and unique to DCs that have been activated through TLRs vs by cytokines. We show that TLR-activated DCs inhibit early IL-4 production by CD4 T cells and thus inhibit their ability to subsequently increase GATA-3 expression and commit to the Th2 lineage. This occurs independently of expression of the GATA-3 antagonist T-bet. Although CD4 T cells activated by TLR-activated DCs make IL-2, they are not capable of phosphorylating STAT5 in response to this cytokine. This inhibition of responsiveness to IL-2 appears to underlie the failure to make early IL-4. Our findings suggest that DCs provide instructional signals for T cell differentiation before cytokine-mediated Th cell selection and outgrowth.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by a National Institutes of Health Grant AI53825 to (E.J.P.).

² Address correspondence and reprint requests to Dr. Edward J. Pearce, University of Pennsylvania, 216 Rosenthal Building, 3800 Spruce Street, Philadelphia, PA 19104. E-mail address: ejpearce{at}mail.med.upenn.edu

³ Abbreviations used in this paper: DC, dendritic cell; Pa, Propionibacterium acnes; Pam₃Cys, S-(2,3-bis(palmitoyloxy)-(2-RS)-propyl)-N-palmitoyl-(R)-Cys-(S)-Ser-(S)-Lys⁴-OH,trihydrochloride; PGN, peptidoglycan; poly(I:C), polyinosinic/polycytidylic acid; pSTAT5, phosphorylated STAT5.

This article has been cited by other articles:

				N. van Panhuys, S.-C. Tang, M. Prout, M. Camberis, D. Scarlett, J. Roberts, J. Hu-Li, W. E. Paul, and G. Le Gros In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation PNAS, August 26, 2008; 105(34): 12423 - 12428. [Abstract] [Full Text] [PDF]

				J. Sun, C. J. Krawczyk, and E. J. Pearce Suppression of Th2 Cell Development by Notch Ligands Delta1 and Delta4 J. Immunol., February 1, 2008; 180(3): 1655 - 1661. [Abstract] [Full Text] [PDF]

				A. S. MacDonald and R. M. Maizels Alarming dendritic cells for Th2 induction J. Exp. Med., January 21, 2008; 205(1): 13 - 17. [Abstract] [Full Text] [PDF]